tiprankstipranks
Trending News
More News >
Sprint Bioscience AB (DE:5JA1)
FRANKFURT:5JA1
Germany Market

Sprint Bioscience AB (5JA1) Financial Statements

Compare
0 Followers

Sprint Bioscience AB Financial Overview

Sprint Bioscience AB's market cap is currently €18.38M. The company's EPS TTM is €0.10087058399999999; its P/E ratio is 1.48; Sprint Bioscience AB is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 167.17Mkr 65.64Mkr 50.48Mkr 83.00Kkr 35.11M
Gross Profitkr 97.33Mkr 37.30Mkr 41.79Mkr -60.91Mkr 24.68M
Operating Incomekr 97.33Mkr -19.67Mkr -845.00Kkr -60.91Mkr -25.47M
EBITDAkr 98.40Mkr -17.32Mkr 396.00Kkr -60.00Mkr -24.49M
Net Incomekr 91.74Mkr -18.28Mkr -438.00Kkr -60.17Mkr -25.35M
Balance Sheet
Cash & Short-Term Investmentskr 126.70Mkr 25.06Mkr 49.93Mkr 29.49Mkr 70.64M
Total Assetskr 136.66Mkr 42.05Mkr 62.38Mkr 37.42Mkr 79.14M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -126.70Mkr -25.06Mkr -49.93Mkr -29.49Mkr -70.64M
Total Liabilitieskr 17.48Mkr 32.78Mkr 34.60Mkr 9.23Mkr 8.68M
Stockholders' Equitykr 119.18Mkr 9.27Mkr 27.77Mkr 28.19Mkr 70.45M
Cash Flow
Free Cash Flowkr 83.44Mkr -24.65Mkr 20.42Mkr -59.05Mkr -42.82M
Operating Cash Flowkr 83.53Mkr -23.36Mkr 22.87Mkr -59.05Mkr -40.12M
Investing Cash Flowkr -54.00Kkr -1.30Mkr -2.45Mkr 0.00kr -2.71M
Financing Cash Flowkr 18.17Mkr -225.00Kkr 24.00Kkr 17.90Mkr 86.39M
Currency in SEK

Sprint Bioscience AB Earnings and Revenue History

Sprint Bioscience AB Debt to Assets

Sprint Bioscience AB Cash Flow

Sprint Bioscience AB Forecast EPS vs Actual EPS